Blog

J&J received a UK licence for Abiraterone (trade name Zytiga) just after midnight last night. The treatment has been proved to have success for some men who have bony metastatic prostate cancer where chemotherapy has failed. Success is shown by reducing or eliminating bone pain and extending survival by a few...